266
Participants
Start Date
April 30, 2011
Primary Completion Date
March 31, 2013
Study Completion Date
June 30, 2013
AZLI
AZLI 75 mg reconstituted with diluent and administered via nebulizer three times daily
Placebo
Placebo to match AZLI administered via nebulizer three times daily
St. Vincent's Hospital, Darlinghurst
Woolcock Institute of Medical Research, Glebe
Concord Hospital, Concord
Westmead Hospital, Westmead
St. George Hospital, Kogarah
Monash Medical Centre, Clayton
Alfred Hospital, Westmead
Peninsula Health, Frankston
The Prince Charles Hospital, Chermside
Mater Adult Hospital, Brisbane
Royla Adelaide Hospital, Adelaide
Repatriation General Hospital, Daws Park
Respiratory Clinical Trials, Toorak Gardens
Royal Perth Hospital, Perth
Sir Charles Gairdner Hospital, Nedlands
St. Luke's Roosevelt Hospital, New York
Jamaica Hospital Medical Center, Jamaica
Winthrop University Hospital - Clinical Trials Center, Mineola
Albany Medical Center, Albany
Drexel University College of Medicine, Philadelphia
University of Pennsylvania Medical Center - Pulmonary, Allergy & Critical Care Division, Philadelphia
Asthma Allergy & Pulmonary Associates, Philadelphia
Pulmonary and Critical Care Associates of Baltimore, Baltimore
Inova Fairfax Hospital/ Heart and Vascular Institute Advanced Lung Disease and Transplant Center, Falls Church
University of Virginia Pulmonary and Critical Care, Charlottesville
Medical University of South Carolina, Charleston
Atlanta Pulmonary Group, Atlanta
University of Florida, Gainesville
Central Florida Pulmonary Group, Orlando
University of Miami - Miller School of Medicine, Miami
Cleveland Clinic Florida, Weston
Bay Area Chest Physicians, Clearwater
Pulmonary Disease Specialists (PDS) Research, Kissimmee
University of Cincinnati / UC Health, Cincinnati
Mayo Clinic, Rochester
Cardio Pulmonary Research at St. Luke's Hospital, Chesterfield
Metroplex Pulmonary and Sleep Center, McKinney
University of Texas Health Science Center at Tyler, Tyler
Alamo Clinical Research Associates, San Antonio
National Jewish Health, Denver
Pulmonary Associates, Phoenix
Arizona Pulmonary Specialists, LTD, Phoenix
St. Joseph's Hospital and Medical Center Heart and Lung Institute, Phoenix
Arizona Pulmonary Specialists, Scottsdale
David Geffen School of Medicine at UCLA, Los Angeles
Landon Pediatric Foundation, Ventura
UC Davis Medical Center Division of Pulmonary, Critical Care and Sleep Medicine, Sacramento
Oregon Health and Science University, Portland
Swedish Medical Center/Minor James Clinic, Seattle
Multicare Pulmonary Specialist, Tacoma
University of Connecticut Health Center, Farmington
University of Calgary, Calgary
University of Alberta, Edmonton
Kelowna Respiratory and Allergy Clinic, Kelowna
The Lung Centre at Vancouver General Hospital, Vancouver
St. Paul's Hospital Pacific Lung Research, Vancouver
Kingston General Hospital / Queen's University, Kingston
St. Michael's Hospital, Toronto
Dr. Anil Dhar Private Practice, Windsor
Centre Hospitalier de L'Université de Montréal Hotel Dieu, Montreal
Lead Sponsor
Gilead Sciences
INDUSTRY